tak 603 has been researched along with dinoprostone in 1 studies
| Studies (tak 603) | Trials (tak 603) | Recent Studies (post-2010) (tak 603) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 16 | 1 | 0 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | tak 603 (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, A; Fukuda, S; Makino, H; Nagai, H; Ohta, Y; Sohda, T; Tsukuda, R | 1 |
1 other study(ies) available for tak 603 and dinoprostone
| Article | Year |
|---|---|
Immunomodulating and articular protecting activities of a new anti-rheumatic drug, TAK-603.
Topics: Adjuvants, Immunologic; Animals; Antirheumatic Agents; Arthritis, Experimental; Autoimmune Diseases; Cartilage; Cells, Cultured; Cytokines; Dinoprostone; Extracellular Matrix; Interleukin-1; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Quinolines; Rabbits; Radiography; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Spleen; Triazoles | 1996 |